{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.666.5.758",
  "meta" : {
    "versionId" : "26",
    "lastUpdated" : "2016-03-31T01:00:12.000-04:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "Lantana EH Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2016-03-31"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.758",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.666.5.758"
  }],
  "version" : "20160331",
  "name" : "IVMacrolidesICU",
  "title" : "IV Macrolides ICU",
  "status" : "active",
  "experimental" : false,
  "date" : "2016-03-31T01:00:12-04:00",
  "publisher" : "Lantana EH Steward",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: This set of values contains medications that are commonly used in an inpatient setting for pneumonia. These medications include intravenous  (IV) Macrolides  that are either specifically mentioned in clinical practice guidelines or are reasonable therapeutic equivalents.),(Data Element Scope: The intent of this data element is to identify patients who are on active medication therapy. Using the Quality Data Model, this particular element will map to the \"Medication, Active\" element.),(Inclusion Criteria: Include Macrolide drugs which are given by the Intravenous Route.),(Exclusion Criteria: The drug concepts should be limited to those which are appropriate for human use and available to be prescribed in the United States. Drug forms that are not consistent with IV administration should not be included. Drugs that take on oral, topical or suppository forms should not be included.)",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "concept" : [{
        "code" : "1668238",
        "display" : "Azithromycin 500 MG Injection"
      },
      {
        "code" : "1668264",
        "display" : "erythromycin lactobionate 500 MG Injection"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:bbbe9993-7ade-4e4f-9028-43e27f03ca09",
    "timestamp" : "2023-09-26T11:16:43-04:00",
    "total" : 2,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1668238",
      "display" : "azithromycin 500 MG Injection"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1668264",
      "display" : "erythromycin lactobionate 500 MG Injection"
    }]
  }
}